J ORTHOP SURG RES 润色咨询

Journal of Orthopaedic Surgery and Research

出版年份:暂无数据 年文章数:3462 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:4.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-06-13 卡恩long 来自福建省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-04-27 kk33333 来自浙江省

    这投稿界面怎么没有submit a new manuscript

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-04-21 ms2000000959270113 来自广东省

    这个杂志需要几个审稿人?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-02-17 kk576 来自安徽省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:脊柱;骨科
    经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-12-29 ms8000001388407167 来自河南省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:关节
    经验分享:一审小修,修回后直接收稿。2周之内就在线published。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-12-08 14818b92m90暂无昵称 来自新疆

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:骨科
    经验分享:投了一篇,审稿回来,又送审了

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-05-18 ms3000000239541394

    审稿速度:1.0
    偏重的研究方向:骨科
    经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。
    看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。
    怪不得是水刊。
    说不定以后被中中国机构预警像Medicine和其他期刊一样

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-02-13 ms1000000637274387 来自广西

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:骨关节
    经验分享:审稿速度算是快了,就是版面费有点贵
    Version 4
    created 03 Feb, 2023
    Editorial decision: Accepted
    On 07 Feb, 2023
    Reviews received
    Received 07 Feb, 2023
    Reviewers agreed
    On 07 Feb, 2023
    Reviewers invited
    Invitations sent on 07 Feb, 2023
    Submission checks complete
    On 06 Feb, 2023
    Submitted to Journal of Orthopaedic Surgery and Research
    On 03 Feb, 2023
    Version 3
    created 08 Dec, 2022
    Editorial decision: Major revision
    On 01 Feb, 2023
    Reviews received
    Received 17 Jan, 2023
    Reviewers agreed
    On 30 Dec, 2022
    Reviewers agreed
    On 16 Dec, 2022
    Reviewers invited
    Invitations sent on 13 Dec, 2022
    Submission checks complete
    On 13 Dec, 2022
    Submitted to Journal of Orthopaedic Surgery and Research
    On 08 Dec, 2022
    Version 2
    created 26 Oct, 2022
    Editorial decision: Major revision
    On 25 Nov, 2022
    Reviews received
    Received 15 Nov, 2022
    Reviewers agreed
    On 01 Nov, 2022
    Reviewers invited
    Invitations sent on 31 Oct, 2022
    Submission checks complete
    On 31 Oct, 2022
    Submitted to Journal of Orthopaedic Surgery and Research
    On 26 Oct, 2022
    Version 1 (private)
    received 22 Oct, 2022
    Editorial decision: Major revision
    On 26 Oct, 2022
    Editor assigned
    On 26 Oct, 2022
    Submission checks complete
    On 25 Oct, 2022
    First submitted to Journal of Orthopaedic Surgery and Research
    On 22 Oct, 2022

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2023-02-11 ms8000000438373883 来自湖北省

    一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2142557, encodeId=29f2214255e8a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一个偏重于方法的文章,3个编辑,意见很好!拒稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec562141958, createdName=卡恩long, createdTime=Tue Jun 13 14:20:46 CST 2023, time=2023-06-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128669, encodeId=22272128669fe, content=这投稿界面怎么没有submit a new manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40375492666, createdName=kk33333, createdTime=Thu Apr 27 14:57:58 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2127433, encodeId=2b47212e43361, content=这个杂志需要几个审稿人?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Fri Apr 21 10:05:34 CST 2023, time=2023-04-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115120, encodeId=edd421151209a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脊柱;骨科<br>经验分享:1月20投稿,12天后大修,2月15修回,2月16接收。很快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Fri Feb 17 16:46:35 CST 2023, time=2023-02-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108053, encodeId=3ff2210805382, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:一审小修,修回后直接收稿。2周之内就在线published。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83116487307, createdName=ms8000001388407167, createdTime=Thu Dec 29 16:29:29 CST 2022, time=2022-12-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104857, encodeId=6530210485e61, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:骨科<br>经验分享:投了一篇,审稿回来,又送审了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcf65268252, createdName=14818b92m90暂无昵称, createdTime=Thu Dec 08 00:24:19 CST 2022, time=2022-12-08, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1220788, encodeId=29eb1220e8877, content=审稿速度:1.0<br>偏重的研究方向:骨科<br>经验分享:之前投稿过两次,昨天第三次投稿也是第二天或者第三天就被editor拒了,后来试了其他的德国期刊就中了,****3分。<br>看来这个期刊是投稿之前需要托关系跟editor联系好了再投稿,不然直接拒了。<br>怪不得是水刊。<br>说不定以后被中中国机构预警像Medicine和其他期刊一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41156464371, createdName=ms3000000239541394, createdTime=Wed May 18 22:33:10 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114508, encodeId=a9532114508e9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:骨关节<br>经验分享:审稿速度算是快了,就是版面费有点贵<br>Version 4<br>created 03 Feb, 2023<br>Editorial decision: Accepted<br>On 07 Feb, 2023<br>Reviews received<br>Received 07 Feb, 2023<br>Reviewers agreed<br>On 07 Feb, 2023<br>Reviewers invited<br>Invitations sent on 07 Feb, 2023<br>Submission checks complete<br>On 06 Feb, 2023<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 03 Feb, 2023<br>Version 3<br>created 08 Dec, 2022<br>Editorial decision: Major revision<br>On 01 Feb, 2023<br>Reviews received<br>Received 17 Jan, 2023<br>Reviewers agreed<br>On 30 Dec, 2022<br>Reviewers agreed<br>On 16 Dec, 2022<br>Reviewers invited<br>Invitations sent on 13 Dec, 2022<br>Submission checks complete<br>On 13 Dec, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 08 Dec, 2022<br>Version 2<br>created 26 Oct, 2022<br>Editorial decision: Major revision<br>On 25 Nov, 2022<br>Reviews received<br>Received 15 Nov, 2022<br>Reviewers agreed<br>On 01 Nov, 2022<br>Reviewers invited<br>Invitations sent on 31 Oct, 2022<br>Submission checks complete<br>On 31 Oct, 2022<br>Submitted to Journal of Orthopaedic Surgery and Research<br>On 26 Oct, 2022<br>Version 1 (private)<br>received 22 Oct, 2022<br>Editorial decision: Major revision<br>On 26 Oct, 2022<br>Editor assigned<br>On 26 Oct, 2022<br>Submission checks complete<br>On 25 Oct, 2022<br>First submitted to Journal of Orthopaedic Surgery and Research<br>On 22 Oct, 2022<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88318288624, createdName=ms1000000637274387, createdTime=Mon Feb 13 23:47:17 CST 2023, time=2023-02-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2114079, encodeId=02c821140e918, content=一审修回拒,莫名其妙,以前垃圾杂志,现在影响因子上来了逼格高了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Sat Feb 11 10:46:04 CST 2023, time=2023-02-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1248153, encodeId=99e51248153ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:关节<br>经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c03026785, createdName=liangweiming, createdTime=Fri Sep 09 16:46:39 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 liangweiming

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:关节
    经验分享:我这个是“4 Reviewer(s) invited 12 Jul 22”,这个还有戏吗,真的是等得难受

    1

    展开1条回复
共210条页码: 2/21页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分